Ohio State University
325 articles about Ohio State University
-
Andelyn Biosciences and The Ohio State University Collaborate for Pre-clinical and GMP Manufacturing of Novel Gene Therapies
11/9/2023
Andelyn Biosciences, Inc., a pioneering and patient-focused cell and gene therapy Contract Development and Manufacturing Organization, is collaborating with The Ohio State University Gene Therapy Institute for the development and clinical manufacturing of novel gene therapies.
-
The Ohio State University and Battelle Partner to Establish new NeuroTech Institute to Help Advance Neurolgical Research and Treatment
10/5/2022
The Ohio State University and Battelle have partnered to launch an independent state-of-the art neurotechnology accelerator focused on treatments for patients with neurological disorders.
-
A new study on Alzheimer's disease ties the brain's immune response to the condition, while scientists have identified a better antibody treatment for cancer and more research news.
-
ATCC Awarded Two Contracts from Gennova Biopharmaceuticals for the Continued Development of Cell Banks to Help Diagnose and Prevent Leishmaniasis
6/13/2022
ATCC to collaborate with Gennova Biopharmaceuticals, the U.S. Food and Drug Administration, Ohio State University, and McGill University on a Leishmania donovani diagnostic test and Leishmania major vaccine.
-
BioVaxys and The Ohio State University Progress Pan-Sarbecovirus Vaccine Research Program
6/3/2022
BioVaxys Technology Corp. announced that The Ohio State University, its research collaborator that is jointly evaluating the Company's novel approach for a "universal vaccine" that can treat a broad range of sarbecoviruses, has completed preparation of the surrogate virus neutralization assays for the SARS-CoV-2 variants, as well as Pangolin-Cov-GD1 and Bat-CoV-RaTG13 sarbecoviruses.
-
Ohio State University Wexner Medical Center Receives Ohio's First Hyperfine Portable MRI Systems to Speed Scanning and Diagnosis for Urgent Brain Injuries
9/16/2021
Hyperfine, Inc. is proud to announce that The Ohio State University Wexner Medical Center is deploying two Swoop™ systems in the emergency room, and the Comprehensive Stroke Center operating room.
-
New Study: Half of Americans Living with Diabetes May be Consuming Less Than the Recommended Amount of Protein, which is Associated with Greater Physical Limitations
7/29/2021
A new study conducted by The Ohio State University and Abbott showed that half of the adults surveyed living with diabetes did not consume the daily recommended intake of protein, which is associated with lower diet quality, increased carbohydrate intake, and greater physical limitations.
-
A new study has found potential in a novel gene therapy method to help children born with the rare genetic and neurodegenerative disorder, AADC deficiency.
-
NMD Pharma Initiates ESTABLISH Study in Patients with Charcot-Marie-Tooth Disease
7/8/2021
NMD Pharma A/S announces that it has initiated the ESTABLISH* study, an international observational study in collaboration with Aarhus University and The Ohio State University to assess neuromuscular function in patients with Charcot-Marie-Tooth disease, an inherited neuromuscular disorder of the peripheral nerves characterized by weakness and fatigue.
-
Battelle, The Ohio State University and Northwestern University Collaborate to Tackle COVID-19 Infodemic in Real Time
5/26/2021
Damage from the COVID-19 pandemic has been amplified by the accompanying “infodemic” of false and misleading online information.
-
Pressure BioSciences and The Ohio State University Announce Food Industry Consortium to Advance Commercialization of PBI's Ultra Shear Technology
2/24/2021
Academia-Industry Partnership to Support Improvements in UST Applications and Allow Global Food Companies Access to UST for Preparation of Safer, More Nutritious Liquid Foods and Beverages [24-February-2021] SOUTH EASTON, Mass. , Feb. 24, 2021 /PRNewswire/ --Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company"), a leader in the development and sale of broa
-
The Ohio State University Introduces Free Online Course on Infection Prevention
2/10/2021
As businesses serving the public cope with heightened and ongoing responsibility to help keep patients, customers, employees and students safe from COVID-19 and other pathogens, the College of Education and Human Ecology at The Ohio State University introduces a free, online course on how to help prevent the spread of infection, with a focus on the important role of cleaning and disinfecting in public spaces.
-
Researchers at Ohio State University are using nanotechnology to boost the body’s ability to fight sepsis, a life-threatening condition that results from the body's extreme reaction to infection.
-
The Ohio State University among five institutions selected as part of $1.7M FDA research contract
11/14/2019
Management sciences researchers will help agency understand, improve pharmaceutical quality management
-
A new method of synthesizing molecule arrangements in medicine could change the way many drugs, including the PARP inhibitor Zejula, a treatment for ovarian cancer, are produced.
-
In Quest to End Cancer, Leading Non-Profit Pelotonia Gives Landmark $102.2 Million for New Immuno-Oncology Institute at The Ohio State University Comprehensive Cancer Center
7/26/2019
Immuno-oncology is considered a promising new treatment for detecting and destroying tumors, giving cancer patients hope of a longer life
-
Madison Startup Otologic Technologies Wins Life Sciences Category in the 2019 Wisconsin Governor's Business Plan Contest
6/11/2019
The Wisconsin Technology Council honored Madison-based health tech startup Otologic Technologies, Inc. with their top award in the Life Sciences Category of the Wisconsin Governor's Business Plan Contest on Wednesday, June 5. Otologic Technologies is developing an artificial intelligence system to help doctors better diagnose ear disease.
-
How Biotechnology Can Save the Planet
4/16/2019
There is a tendency to look at biotech as being all about developing drugs. And, of course, that is the primary focus of BioSpace. However, from time to time it’s a good idea to remind ourselves that biotech can and does have broader applications besides medicines, and can, in fact, impact our da... -
UAHC Subsidiary American Sustainable Rubber Company, LLC Signs Royalty Agreement with The Ohio State University for Exclusive Rights of Genetically Modified TK Rubber Dandelion
4/9/2019
United American Healthcare Corporation announced that American Sustainable Rubber Company, LLC and The Ohio State University signed a royalty agreement for exclusive rights within the United States to the genetically modified TK Rubber Dandelion, developed at The Ohio State University, to be grown in an indoor hydroponic system for natural rubber production.
-
Although that is good news, cancer is the second-most common cause of death in the U.S., with more than 1.7 million new cancer cases each year and more than 600,000 cancer deaths. The report notes that one of the biggest factors in decreased cancer rates are lower tobacco smoking rates.